{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:09:16Z","timestamp":1775020156010,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["NP-103-PP-02"],"award-info":[{"award-number":["NP-103-PP-02"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST-104-2314-B-400-007-MY22"],"award-info":[{"award-number":["MOST-104-2314-B-400-007-MY22"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.pnpbp.2016.06.002","type":"journal-article","created":{"date-parts":[[2016,6,12]],"date-time":"2016-06-12T06:50:14Z","timestamp":1465714214000},"page":"7-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice"],"prefix":"10.1016","volume":"71","author":[{"given":"Jen-Cheng","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Huan","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Yi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwei-Hsien","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2016.06.002_bb0005","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0278-5846(03)00080-0","article-title":"Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia","volume":"27","author":"Becker","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0010","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/npp.2012.246","article-title":"GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects","volume":"38","author":"Burgdorf","year":"2013","journal-title":"Neuropsychopharmacol. Off. Publ. Amer. College Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0015","first-page":"75","article-title":"Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy","volume":"4","author":"Caddy","year":"2014","journal-title":"Adv. Psychol."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0020","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.addbeh.2013.01.014","article-title":"Effects of chronic ketamine use on frontal and medial temporal cognition","volume":"38","author":"Chan","year":"2013","journal-title":"Addict. Behav."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.schres.2012.01.024","article-title":"Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine","volume":"136","author":"Chan","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00213-008-1103-1","article-title":"Attenuation of ketamine-evoked behavioral responses by mGluR5 positive modulators in mice","volume":"198","author":"Chan","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0035","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.taap.2012.10.004","article-title":"Sarcosine attenuates toluene-induced motor incoordination, memory impairment, and hypothermia but not brain stimulation reward enhancement in mice","volume":"265","author":"Chan","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0040","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.2174\/1381612819666140110121908","article-title":"NMDA pathology and treatment of schizophrenia","volume":"20","author":"Chang","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0045","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fnbeh.2015.00162","article-title":"AMPA receptor-mTOR activation is required for the antidepressant-like effects of sarcosine during the forced swim test in rats: insertion of AMPA receptor may play a role","volume":"9","author":"Chen","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0050","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1523\/JNEUROSCI.3481-08.2009","article-title":"HCN1 channel subunits are a molecular substrate for hypnotic actions of ketamine","volume":"29","author":"Chen","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0055","unstructured":"Chia N, 1962-, Wong DLF. The effectiveness of dimethylglycine (DMG) as dietary supplement and adjunct intervention to P.E.C.S. approach in treatment of children with autism spectrum disorder (ASD) and severe speech delay. J. Amer. Acad. Special Educ. Prof. (JAASEP). 2009."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0060","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biopsych.2012.05.009","article-title":"Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia","volume":"72","author":"D'Souza","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0065","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269881114527361","article-title":"Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic","volume":"28","author":"Diamond","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0070","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ddstr.2006.11.012","article-title":"Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action","volume":"3","author":"Du","year":"2006","journal-title":"Drug Discov. Today Ther. Strateg."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2014.10.028","article-title":"Ketamine and other potential glutamate antidepressants","volume":"225","author":"Dutta","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tibs.2005.04.004","article-title":"Glycine transporters: essential regulators of neurotransmission","volume":"30","author":"Eulenburg","year":"2005","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0085","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0091-3057(85)90288-6","article-title":"Prevention of strychnine-induced seizures and death by the N-methylated glycine derivatives betaine, dimethylglycine and sarcosine","volume":"22","author":"Freed","year":"1985","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0090","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","article-title":"Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus","volume":"32","author":"Garcia","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0095","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.biopsych.2013.02.020","article-title":"Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression","volume":"74","author":"Huang","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0100","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00702-015-1500-7","article-title":"Treatment escalation in patients not responding to pharmacotherapy, psychotherapy, and electro-convulsive therapy: experiences from a novel regimen using intravenous S-ketamine as add-on therapy in treatment-resistant depression","volume":"123","author":"Kallmunzer","year":"2016","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0105","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00213-008-1151-6","article-title":"Glycine and d-serine, but not d-cycloserine, attenuate prepulse inhibition deficits induced by NMDA receptor antagonist MK-801","volume":"198","author":"Kanahara","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0110","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbr.2007.07.033","article-title":"d-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats","volume":"186","author":"Karasawa","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0115","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s007020050233","article-title":"NMDA receptor antagonists acting at the glycineB site in rat models for antipsychotic-like activity","volume":"106","author":"Karcz-Kubicha","year":"1999","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0120","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbr.2014.09.046","article-title":"Effects of a glycine transporter-1 inhibitor and d-serine on MK-801-induced immobility in the forced swimming test in rats","volume":"278","author":"Kawaura","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2011.05.035","article-title":"Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression","volume":"224","author":"Koike","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00213-004-1982-8","article-title":"Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects","volume":"179","author":"Krystal","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0006-3223(99)00097-9","article-title":"Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions","volume":"47","author":"Krystal","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0140","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archpsyc.62.11.1196","article-title":"Sarcosine or d-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study","volume":"62","author":"Lane","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0145","first-page":"451","article-title":"A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and d-serine add-on treatment for schizophrenia","volume":"13","author":"Lane","year":"2010","journal-title":"Int. J. Neuropsychopharmacol. Off. Scie. J. Colleg. Int. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biopsych.2007.04.038","article-title":"Sarcosine (N-methylglycine) treatment for acute schizophrenia: a randomized, double-blind study","volume":"63","author":"Lane","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0155","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/S0006-3223(03)00374-3","article-title":"Prepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal-lesioned rats: reversal by glycine and a glycine transporter inhibitor","volume":"54","author":"Le Pen","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0160","first-page":"888","article-title":"Inhibition of HCN1 channels by ketamine accounts for its antidepressant actions","volume":"45","author":"Li","year":"2014","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0165","article-title":"Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: a randomised, double-blind, placebo-controlled trial","volume":"1-12","author":"Lin","year":"2015","journal-title":"World J. Biol. Psychiat. Off. J. World Feder. Soc. Biol.Psychiatry."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0170","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00213-005-2210-x","article-title":"Modulators of the glycine site on NMDA receptors, d-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia","volume":"179","author":"Lipina","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0175","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1046\/j.1471-4159.1998.71052211.x","article-title":"Differential properties of two stably expressed brain-specific glycine transporters","volume":"71","author":"Lopez-Corcuera","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0180","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11920-007-0063-1","article-title":"The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects","volume":"9","author":"Maeng","year":"2007","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0185","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0190","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1176\/jnp.2010.22.4.442","article-title":"The use of a series of ketamine infusions in two patients with treatment-resistant depression","volume":"22","author":"Messer","year":"2010","journal-title":"J. Nuropsychiat. Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0195","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/cns.12099","article-title":"Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings)","volume":"19","author":"Mion","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0200","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0205","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pharmthera.2010.07.004","article-title":"Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism","volume":"128","author":"Neill","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0210","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(98)00067-0","article-title":"Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis","volume":"20","author":"Newcomer","year":"1999","journal-title":"Neuropsychopharmacol. Off.Publ. Amer. College Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0215","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-2999(96)00675-9","article-title":"Antidepressant-like effects of 1-aminocyclopropanecarboxylic acid and d-cycloserine in an animal model of depression","volume":"316","author":"Papp","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0220","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/WNR.0b013e3283381a4e","article-title":"Glycine transporter inhibition reverses ketamine-induced working memory deficits","volume":"21","author":"Roberts","year":"2010","journal-title":"Neuroreport"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0225","doi-asserted-by":"crossref","first-page":"234295","DOI":"10.1155\/2014\/234295","article-title":"Glix 13, a new drug acting on glutamatergic pathways in children and animal models of autism spectrum disorders","volume":"2014","author":"Santini","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0230","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1213\/00000539-199610000-00031","article-title":"Ketamine blocks currents through mammalian nicotinic acetylcholine receptor channels by interaction with both the open and the closed state","volume":"83","author":"Scheller","year":"1996","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0235","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00213-010-1794-y","article-title":"d-Serine and a glycine transporter-1 inhibitor enhance social memory in rats","volume":"209","author":"Shimazaki","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0240","doi-asserted-by":"crossref","unstructured":"Singh JB, Fedgchin M, Daly EJ, De Boer P, Cooper K, Lim P, et al. A Double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression. Am. J. Psychiatry. 2016:(appiajp201616010037).","DOI":"10.1176\/appi.ajp.2016.16010037"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0245","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0896-6273(92)90207-T","article-title":"Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors","volume":"8","author":"Smith","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0250","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ana.410170225","article-title":"Dimethylglycine and reduction of mortality in penicillin-induced seizures","volume":"17","author":"Ward","year":"1985","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0255","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/acm.2010.0146","article-title":"Effectiveness of nutritional supplements for reducing symptoms in autism-spectrum disorder: a case report","volume":"17","author":"Xia","year":"2011","journal-title":"J. Altern. Complement. Med."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0260","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00726-012-1347-2","article-title":"The involvement of AMPA-ERK1\/2-BDNF pathway in the mechanism of new antidepressant action of prokinetic meranzin hydrate","volume":"44","author":"Xie","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0265","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2009.11.058","article-title":"The effects of glycine transporter I inhibitor, N-methylglycine (sarcosine), on ketamine-induced alterations in sensorimotor gating and regional brain c-Fos expression in rats","volume":"469","author":"Yang","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0270","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0275","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1113\/jphysiol.2009.168757","article-title":"The glycine transport inhibitor sarcosine is an NMDA receptor co-agonist that differs from glycine","volume":"587","author":"Zhang","year":"2009","journal-title":"J. Physiol."},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0280","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1007\/s00213-015-4062-3","article-title":"Comparison of ketamine, 7.8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression","volume":"232","author":"Zhang","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2016.06.002_bb0285","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/mp.2013.87","article-title":"Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties","volume":"18","author":"Zunszain","year":"2013","journal-title":"Mol. Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584616300811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584616300811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T12:57:27Z","timestamp":1568033847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584616300811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":57,"alternative-id":["S0278584616300811"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2016.06.002","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2016.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}